The FDA this week put its highest-risk label on a recall of HeartWare International’s (NSDQ:HTWR) circulatory support system over concerns about failed locking mechanisms that could leave the implants without power. The FDA gave the recall, initiated in December 2013, a Class I classification, reserved for defects that the agency believes “will cause serious adverse health consequences or death.” HeartWare reissued warnings this month remind doctors of the manufacturing defect, which puts patients at risk of losing circulatory support.
Help employers find you! Check out all the jobs and post your resume.
